Cigna earnings beat by $0.04, revenue topped estimates
Ansys (NASDAQ:ANSS) Inc stock reached a 52-week high, hitting 369.26 USD, marking a significant milestone for the company. With an impressive market capitalization of $32.34 billion and industry-leading gross profit margins of 92.48%, the company demonstrates robust financial fundamentals. InvestingPro analysis reveals 16 additional key insights about ANSS’s performance and valuation. Over the past year, Ansys has experienced a positive shift in its stock performance, with revenue growth of 15.98% and a strong current ratio of 3.66, indicating excellent liquidity. This upward trend reflects investor confidence and the company’s robust market position. The achievement of this 52-week high underscores Ansys’s strong financial health - rated as "GREAT" by InvestingPro analysts - and potential for continued growth in the competitive technology sector.
In other recent news, Ansys reported first-quarter 2025 results that did not meet analyst expectations. The company posted revenue of $504.9 million, which was an 8.2% increase year-over-year but fell short of the anticipated $528.28 million. Adjusted earnings per share were $1.64, missing projections of $1.76. Ansys reported an annual contract value of $410.1 million, a modest 0.7% growth compared to the first quarter of 2024. The company continues to project double-digit annual contract value growth for fiscal year 2025. Meanwhile, Ansys is awaiting final regulatory approval from China for its proposed $35 billion merger with Synopsys (NASDAQ:SNPS). The merger has already received clearance in all other jurisdictions. However, China’s market regulator has postponed approval amid tightened chip export controls by the U.S. government. Additionally, Ansys shareholders recently elected directors and ratified Deloitte & Touche LLP as the independent auditor for fiscal year 2025.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.